COHANCE / NSE / Biotechnology & Drugs
Cohance Lifesciences
1Y Price Trend
Key Information
Recommendations
RatingHold
Target High1,121.15
Target Low267.85
Target Mean3.25
Target Median81.25
Risk Metrics
Overall RiskHigh risk
Board Risk53.83
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Cohance Lifesciences shareholders back Umang Vohra as Chairman and Group CEO Indian Pharma Post
COHANCE LIFESCIENCES LTD Share Price Today - Live COHANCE Stock Price for NSE/BSE Upstox
Cohance Lifesciences to attend investor meets in June scanx.trade
Cohance Lifesciences Ltd Reports Steep Decline in Quarterly Financial Performance Amid Sector Challenges Markets Mojo
Cohance Lifesciences Q3 FY26: Profit Plunges 76% as Margin Pressures Mount Markets Mojo
Cohance Lifesciences revises 360 ONE Capital conference date to May 29 scanx.trade
Cohance Lifesciences Ltd Surges 7.57% to Day's High of Rs 458.8 — Outperforms Sector by 4.75 Percentage Points Markets Mojo
Cohance FY26 Revenue Falls 13%; Recovery Set for H2 FY27 scanx.trade
© SharekeyX | Rusaka Technologies 2024-2026